Exploiting microRNA regulation for genetic engineering

Tissue Antigens

Volumn 80, Issue 5, 2012, Pages 393-403

  Gentner, B ^a,b   Naldini, L ^a,b  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Gene therapy; microRNA regulated vectors; miRNA regulation; Post transcriptional detargeting

Indexed keywords

BLOOD CLOTTING FACTOR 9; COMPLEMENTARY DNA; LENTIVIRUS VECTOR; MICRORNA; ONCOLYTIC VIRUS; PARVOVIRUS VECTOR;

BIOENGINEERING; CANCER GENE THERAPY; CELL SUBPOPULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC ENGINEERING; GENETIC REGULATION; GENETIC TRANSDUCTION; HUMAN; NONHUMAN; ONCOLYTIC VIROTHERAPY; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PURIFICATION; REVIEW; RNA SEQUENCE; TISSUE SPECIFICITY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIROTHERAPY; VIRUS REPLICATION;

ANIMALS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; MICE; MICRORNAS; ONCOLYTIC VIROTHERAPY; RNA, SMALL INTERFERING; TRANSFECTION; TRANSGENES; VIRAL TROPISM; VIRUSES;

EID: 84866869441     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12002     Document Type: Review

References (105)

1. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001: 294: 853-8.
2. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001: 294: 858-62.
3. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001: 294: 862-4.
4. Pasquinelli AE, Reinhart BJ, Slack F et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000: 408: 86-9.
5. Sharp PA. The centrality of RNA. Cell 2009: 136: 577-80.
6. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009: 19: 92-105.
7. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004: 5: 522-31.
8. Landgraf P, Rusu M, Sheridan R et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007: 129: 1401-14.
9. Berezikov E. Evolution of microRNA diversity and regulation in animals. Nat Rev Genet 2011: 12: 846-60.
10. Yang JS, Lai EC. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell 2011: 43: 892-903.
11. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009: 136: 215-33.
12. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010: 38: 789-802.
13. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010: 466: 835-40.
14. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011: 12: 99-110.
15. Ameres SL, Horwich MD, Hung JH et al. Target RNA-directed trimming and tailing of small silencing RNAs. Science 2010: 328: 1534-9.
16. Di Giammartino DC, Nishida K, Manley JL. Mechanisms and consequences of alternative polyadenylation. Mol Cell 2011: 43: 853-66.
17. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol 2010: 20: R858-61.
18. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010: 11: 597-610.
19. Yi R, Fuchs E. MicroRNAs and their roles in mammalian stem cells. J Cell Sci 2011: 124: 1775-83.
20. Rosenfeld N, Aharonov R, Meiri E et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008: 26: 462-9.
21. Mi S, Lu J, Sun M et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A 2007: 104: 19971-6.
22. Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 2008: 320: 97-100.
23. Li QJ, Chau J, Ebert PJ et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007: 129: 147-61.
24. Xiao C, Calado DP, Galler G et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007: 131: 146-59.
25. Park CY, Choi YS, McManus MT. Analysis of microRNA knockouts in mice. Hum Mol Genet 2010: 19: R169-75.
26. Magill ST, Cambronne XA, Luikart BW et al. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci U S A 2010: 107: 20382-7.
27. Boldin MP, Taganov KD, Rao DS et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011: 208: 1189-201.
28. Lu TX, Hartner J, Lim EJ et al. microRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 2011: 187: 3362-73.
29. Ma X, Kumar M, Choudhury SN et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci USA 2011: 108: 10144-9.
30. Choi YJ, Lin CP, Ho JJ et al. miR-34 miRNA provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011: 13: 1353-60.
31. Kogure T, Costinean S, Yan I, Braconi C, Croce C, Patel T. Hepatic miR-29ab1 expression modulates chronic hepatic injury. J Cell Mol Med 2012 (Epub ahead of print).
32. Prosser HM, Koike-Yusa H, Cooper JD, Law FC, Bradley A. A resource of vectors and ES cells for targeted deletion of microRNAs in mice. Nat Biotechnol 2011: 29: 840-5.
33. Lennox KA, Behlke MA. Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther 2011: 18: 1111-20.
34. Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA 2010: 16: 2043-50.
35. Broderick JA, Zamore PD. MicroRNA therapeutics. Gene Ther 2011: 18: 1104-10.
36. Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011: 11: 849-64.
37. Gentner B, Schira G, Giustacchini A et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009: 6: 63-6.
38. Brown BD, Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 2009: 10: 578-85.
39. Care A, Catalucci D, Felicetti F et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007: 13: 613-8.
40. Xie J, Ameres SL, Friedline R et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods 2012: 9: 403-9.
41. Amendola M, Passerini L, Pucci F, Gentner B, Bacchetta R, Naldini L. Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform. Mol Ther 2009: 17: 1039-52.
42. Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci U S A 2005: 102: 13212-7.
43. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008: 455: 64-71.
44. Ascano M, Hafner M, Cekan P, Gerstberger S, Tuschl T. Identification of RNA-protein interaction networks using PAR-CLIP. Wiley Interdiscip Rev RNA 2012: 3: 159-77.
45. Darnell RB. HITS-CLIP: panoramic views of protein-RNA regulation in living cells. Wiley Interdiscip Rev RNA 2010: 1: 266-86.
46. Brown BD, Venneri MA, Zingale A, Sergi Sergi L, Naldini L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 2006: 12: 585-91.
47. Brown BD, Gentner B, Cantore A et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007: 25: 1457-67.
48. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002: 297: 2056-60.
49. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007: 4: 721-6.
50. Scherr M, Venturini L, Battmer K et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 2007: 35: e149.
51. Baccarini A, Chauhan H, Gardner TJ, Jayaprakash AD, Sachidanandam R, Brown BD. Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Curr Biol 2011: 21: 369-76.
52. Baccarini A, Chauhan H, Gardner T, Ruzo A, Sachidanandam R, Brown BD. Modifying target structure greatly improves the efficiency of microrna-regulated vectors. Mol Ther 2011: 19: S14 Abstract.
53. Gentner B, Visigalli I, Hiramatsu H et al. Identification of hematopoietic stem cell-specific miRNA enables gene therapy of globoid cell leukodystrophy. Sci Transl Med 2010: 2: 58ra84.
54. Di Stefano B, Maffioletti SM, Gentner B et al. A microRNA-based system for selecting and maintaining the pluripotent state in human induced pluripotent stem cells. Stem Cells 2011: 29: 1684-95.
55. Kamata M, Liang M, Liu S, Nagaoka Y, Chen IS. Live cell monitoring of hiPSC generation and differentiation using differential expression of endogenous microRNAs. PLoS One 2010: 5: e11834.
56. Sachdeva R, Jonsson ME, Nelander J et al. Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors. Proc Natl Acad Sci U S A 2010: 107: 11602-7.
57. Akerblom M, Sachdeva R, Barde I et al. MicroRNA-124 is a subventricular zone neuronal fate determinant. J Neurosci 2012: 32: 8879-89.
58. Brown BD, Cantore A, Annoni A et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 2007: 110: 4144-52.
59. Annoni A, Brown BD, Cantore A, Sergi LS, Naldini L, Roncarolo MG. In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance. Blood 2009: 114: 5152-61.
60. Matsui H, Hegadorn C, Ozelo M et al. A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A. Mol Ther 2011: 19: 723-30.
61. Suzuki T, Sakurai F, Nakamura S et al. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy. Mol Ther 2008: 16: 1719-26.
62. Cawood R, Chen HH, Carroll F, Bazan-Peregrino M, van Rooijen N, Seymour LW. Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog 2009: 5: e1000440.
63. Leja J, Nilsson B, Yu D et al. Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability. PLoS One 2010: 5: e8916.
64. Ylosmaki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J Virol 2008: 82: 11009-15.
65. Fu X, Rivera A, Tao L, De Geest B, Zhang X. Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells. Mol Ther 2012: 20: 339-46.
66. Cawood R, Wong SL, Di Y, Baban DF, Seymour LW. MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity. PLoS One 2011: 6: e16152.
67. Kelly EJ, Hadac EM, Greiner S, Russell SJ. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 2008: 14: 1278-83.
68. Skalsky RL, Cullen BR. Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One 2011: 6: e24248.
69. Kelly EJ, Nace R, Barber GN, Russell SJ. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J Virol 2010: 84: 1550-62.
70. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. Harnessing endogenous miRNA to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 2008: 4: 239-48.
71. Heiss BL, Maximova OA, Pletnev AG. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J Virol 2011: 85: 1464-72.
72. Yen LC, Lin YL, Sung HH et al. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome. Vaccine 2011 (Epub ahead of print).
73. Papapetrou EP, Kovalovsky D, Beloeil L, Sant'angelo D, Sadelain M. Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras. J Clin Invest 2009: 119: 157-68.
74. Jin H, Lv S, Yang J et al. Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells. PLoS One 2011: 6: e21307.
75. Sugio K, Sakurai F, Katayama K et al. Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporation of normal cell-specific microRNA-targeted sequences. Clin Cancer Res 2011: 17: 2807-18.
76. Lee CY, Rennie PS, Jia WW. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Clin Cancer Res 2009: 15: 5126-35.
77. Hikichi M, Kidokoro M, Haraguchi T et al. MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy. Mol Ther 2011: 19: 1107-15.
78. Geisler A, Jungmann A, Kurreck J et al. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther 2011: 18: 199-209.
79. Xie J, Xie Q, Zhang H et al. microRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression. Mol Ther 2011: 19: 526-35.
80. Mansfield JH, Harfe BD, Nissen R et al. MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 2004: 36: 1079-83.
81. Zeng Y, Cullen BR. Sequence requirements for micro RNA processing and function in human cells. RNA 2003: 9: 112-23.
82. Amendola M, Venneri MA, Biffi A, Vigna E, Naldini L. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol 2005: 23: 108-16.
83. Mukherji S, Ebert MS, Zheng GX, Tsang JS, Sharp PA, van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat Genet 2011: 43: 854-9.
84. Mullokandov G, Baccarini A, Ruzo A et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 2012: 9: 840-6.
85. Thai TH, Calado DP, Casola S et al. Regulation of the germinal center response by microRNA-155. Science 2007: 316: 604-8.
86. Lee JY, Kim S, Hwang do W et al. Development of a dual-luciferase reporter system for in vivo visualization of microRNA biogenesis and posttranscriptional regulation. J Nucl Med 2008: 49: 285-94.
87. Follenzi A, Battaglia M, Lombardo A, Annoni A, Roncarolo MG, Naldini L. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 2004: 103: 3700-9.
88. Goudy KS, Annoni A, Naldini L, Roncarolo MG. Manipulating immune tolerance with micro-rna regulated gene therapy. Front Microbiol 2011: 2: 221.
89. Matrai J, Cantore A, Bartholomae CC et al. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology 2011: 53: 1696-707.
90. Kron MW, Espenlaub S, Engler T, Schirmbeck R, Kochanek S, Kreppel F. miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigens. Mol Ther 2011: 19: 1547-57.
91. Colin A, Faideau M, Dufour N et al. Engineered lentiviral vector targeting astrocytes in vivo. Glia 2009: 57: 667-79.
92. Lattanzi A, Gentner B, Schira G, Maderna C, Naldini L, Gritti A. Endogenous microRNA regulation during neural stem cell differentiation in vitro. Hum Gene Ther 2008: 19: 1082 Abstract.
93. Aiuti A, Cattaneo F, Galimberti S et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009: 360: 447-58.
94. Capotondo A, Cesani M, Pepe S et al. Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy. Hum Gene Ther 2007: 18: 821-36.
95. Grez M, Reichenbach J, Schwable J, Seger R, Dinauer MC, Thrasher AJ. Gene therapy of chronic granulomatous disease: the engraftment dilemma. Mol Ther 2011: 19: 28-35.
96. Lachmann N, Jagielska J, Heckl D et al. MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. Gene Ther 2011: 19: 915-24.
97. Papapetrou EP, Korkola JE, Sadelain M. A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells. Stem Cells 2010: 28: 287-96.
98. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 2003: 9: 789-95.
99. Pucci F, Venneri MA, Biziato D et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009: 114: 901-14.
100. Edge RE, Falls TJ, Brown CW, Lichty BD, Atkins H, Bell JC. A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol Ther 2008: 16: 1437-43.
101. Leber MF, Bossow S, Leonard VH et al. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Mol Ther 2011: 19: 1097-106.
102. Lauring AS, Jones JO, Andino R. Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol 2010: 28: 573-9.
103. Perez JT, Pham AM, Lorini MH, Chua MA, Steel J, tenOever BR. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat Biotechnol 2009: 27: 572-6.
104. Pham AM, Langlois RA, tenOever BR. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog 2012: 8: e1002465.
105. Kamrud KI, Coffield VM, Owens G et al. In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs. J Virol 2010: 84: 7713-25.